ACH — Accendra Health, Inc.

Owens & Minor Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics:

• Revenue: $697 million for Q3 2025, up from $687 million in Q3 2024. Adjusted for a $6 million one-time revenue benefit in the prior year, growth was approximately 3.4%.
• Adjusted EBITDA: $92 million, down from $108 million in Q3 2024, impacted by the prior year's one-time benefit and rising product costs.
• Adjusted Net Income: $0.25 per share, compared to $0.36 per share in Q3 2024. Year-to-date adjusted net income per share increased to $0.80 from $0.64.
• Net Debt: $2.1 billion as of September 30, 2025, reflecting costs related to the exit of a planned acquisition and challenges with a new kitting facility.
• Free Cash Flow: $28 million in Q3 2025 and $78 million year-to-date, with continuing operations generating cash despite challenges from discontinued operations.

2. Strategic Updates and Business Highlights:

• Divestiture Announcement: Owens & Minor announced a definitive agreement to sell its Products & Healthcare Services (P&HS) segment to Platinum Equity, allowing a focus on its higher-margin Patient Direct business.
• Market Positioning: The company aims to enhance its position in home-based care, leveraging its existing infrastructure and expanding payer relationships, particularly in diabetes and sleep apnea markets.
• Technology Investments: Future investments will focus on technology and automation to improve patient experience and operational efficiency.

3. Forward Guidance and Outlook:

• 2025 Guidance: The company reaffirmed its full-year revenue guidance of $2.76 billion to $2.82 billion, adjusted net income between $1.02 and $1.07 per share, and adjusted EBITDA between $376 million and $382 million. Q4 revenue is expected to show seasonal improvement.
• 2026 Outlook: While specific guidance for 2026 is not yet provided, management anticipates strong growth, barring a significant customer loss that will impact profitability.

4. Challenges and Points of Concern:

• Customer Loss Impact: A notable customer loss is expected in 2026, which could affect revenue and profitability, although it is not anticipated to significantly impact cash flow due to the low margin of the contract.
• Operational Challenges: The startup of a new kitting facility has led to temporary inventory imbalances, affecting cash flow and operational efficiency.
• Increased Debt Levels: The company’s net debt has risen due to costs associated with the divestiture and operational challenges, raising concerns about financial flexibility.

5. Notable Q&A Insights:

• Durability of Trends: Management expressed confidence in the sustainability of growth trends in home-based care, although they acknowledged the upcoming customer loss.
• Optum Channel: The new preferred provider agreement with Optum is in early stages, with potential for significant growth as the company leverages its sales force to access a large network of referral sources.
• Covenant Compliance: The company confirmed it remains in compliance with its debt covenants and expects to maintain this status post-divestiture.
• Kitting Facility Issues: The over-acquisition of inventory for the new kitting facility is expected to resolve in the coming months, which should alleviate some cash flow pressures.

Overall, Owens & Minor is transitioning towards a focused strategy in home-based care, while navigating operational challenges and preparing for a significant shift in its business structure with the upcoming divestiture.